Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C34H41N3O4 |
| Molecular Weight | 555.707 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCOC1=C(CC(O)=O)C=C(C=C1)C2=CC=CC(CCCC3=NN(CC4=CC=C(C=C4)C(C)(C)C)C(=O)N3CC)=C2
InChI
InChIKey=KUPVZYDOHAPPNF-UHFFFAOYSA-N
InChI=1S/C34H41N3O4/c1-6-36-31(35-37(33(36)40)23-25-14-17-29(18-15-25)34(3,4)5)13-9-11-24-10-8-12-26(20-24)27-16-19-30(41-7-2)28(21-27)22-32(38)39/h8,10,12,14-21H,6-7,9,11,13,22-23H2,1-5H3,(H,38,39)
| Molecular Formula | C34H41N3O4 |
| Molecular Weight | 555.707 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 02:36:13 GMT 2025
by
admin
on
Wed Apr 02 02:36:13 GMT 2025
|
| Record UNII |
1EQ4LQN9N3
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
1EQ4LQN9N3
Created by
admin on Wed Apr 02 02:36:13 GMT 2025 , Edited by admin on Wed Apr 02 02:36:13 GMT 2025
|
PRIMARY | |||
|
13450
Created by
admin on Wed Apr 02 02:36:13 GMT 2025 , Edited by admin on Wed Apr 02 02:36:13 GMT 2025
|
PRIMARY | |||
|
76285852
Created by
admin on Wed Apr 02 02:36:13 GMT 2025 , Edited by admin on Wed Apr 02 02:36:13 GMT 2025
|
PRIMARY | |||
|
1616372-41-8
Created by
admin on Wed Apr 02 02:36:13 GMT 2025 , Edited by admin on Wed Apr 02 02:36:13 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR |
PPAR? antagonist leading to the inhibition of fatty acid oxidation which is critical for the survival of tumor cells
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
|